SGLT2 inhibitors reduce the salt sensitivity of blood pressure in type 2 diabetes via enhanced postprandial natriuresis.

Cardiovasc Diabetol · 2026 · PMC13037050 · PMID 41736122

Europe PMC DOI

hedged sentence

0.0650

closest p · 1.3× alpha

0.0650

boldest claim

The sentences

did not reach statistical significancep = 0.065so close (0.05 < p ≤ 0.1)

7.1 [3.7, 20.5] mUI/l; p = 0.044), with marked interindividual variability, whereas in the SGLT2i group the increase did not reach statistical significance (24.9 [10.9, 160.2] vs. 9.5 [5.2, 17.4] mU/L; p = 0.065).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.